Risks and Precautions When Using Macrolides and Statins Together

Key Interactions and Risks

Macrolide antibiotics, particularly clarithromycin and erythromycin, inhibit the cytochrome P-450 3A4 isozyme, leading to increased statin blood levels and risk of toxicity, as noted by the European Heart Journal and the Journal of the American College of Cardiology 1, 2

Advanced age, especially over 80 years, is a risk factor for adverse events when using macrolides and statins together, according to Praxis Medical Insights 3
Female sex and small body frame are also risk factors for adverse events when using macrolides and statins together, as reported by Praxis Medical Insights 4, 3
Multisystem disease, particularly chronic renal insufficiency, increases the risk of adverse events when using macrolides and statins together, as noted by Praxis Medical Insights 4, 3
Polypharmacy, or the use of multiple medications, is a risk factor for adverse events when using macrolides and statins together, according to Praxis Medical Insights 4, 3
Concomitant use of other medications that affect statin metabolism increases the risk of adverse events when using macrolides and statins together, as reported by Praxis Medical Insights 4
Higher statin doses increase the risk of adverse effects when using macrolides and statins together, according to Praxis Medical Insights 3

Mild symptoms of statin-macrolide interaction include non-specific muscle aches or joint pains without significant CK elevation, as noted by the Journal of the American College of Cardiology 2
Moderate symptoms include muscle pain with mild-to-moderate CK elevations, according to the Journal of the American College of Cardiology 2
Severe symptoms include myositis with muscle weakness, pain, and CK elevations, as reported by the Journal of the American College of Cardiology 2
Life-threatening symptoms include rhabdomyolysis with myoglobinuria and acute renal failure, according to the Journal of the American College of Cardiology 2

The American College of Cardiology recommends monitoring for muscle symptoms in patients taking atorvastatin and macrolides together 2
The American College of Cardiology also recommends discontinuing statin therapy if severe myopathy develops or CK levels exceed 10 times the upper limit of normal 2

The American College of Cardiology recommends assessing for muscle symptoms before starting combined therapy and instructing patients to report muscle pain, tenderness, or weakness immediately 2
Praxis Medical Insights recommends considering baseline CK measurement in high-risk patients and obtaining CK measurements when patients report muscle symptoms 3
The American College of Cardiology recommends discontinuing statin therapy if severe myopathy develops or CK levels exceed 10 times the upper limit of normal 2